Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 8.

Journal Article

Aleksandrova, Krasimira, Leise, Jana, Priesner, Christoph, Melk, Anette, Kubaink, Fanni, Abken, Hinrich, Hombach, Andreas, Aktas, Murat, Essl, Mike, Buerger, Iris, Kaiser, Andrew, Rauser, Georg, Jurk, Marion, Goudeva, Lilia, Glienke, Wolfgang, Arseniev, Lubomir, Esser, Ruth and Koehl, Ulrike (2019). Functionality and Cell Senescence of CD4/CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy (R) Platform. Transfus. Med. Hemother., 46 (1). S. 47 - 55. BASEL: KARGER. ISSN 1660-3818

Kloess, Stephan, Chambron, Nicole, Gardlowski, Tanja, Weil, Sandra, Koch, Joachim, Esser, Ruth, von Strandmann, Elke Pogge, Morgan, Michael A., Arseniev, Lubomir, Seitz, Oliver and Koehl, Ulrike (2015). Cetuximab reconstitutes pro-inflammatory cytokine secretions and tumor-infiltrating capabilities of sMICA-inhibited NK cells in HNSCC tumor spheroids. Front. Immunol., 6. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224

Kloess, Stephan, da Silva, Alessa Ede Valverde, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael, von Strandmann, Elke Pogge and Koehl, Ulrike (2018). Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset (vol 8, 1100, 2017). Front. Immunol., 9. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224

Kloess, Stephan, da Silva, Alessa Ede Valverde, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael ORCID: 0000-0001-5318-9044, von Strandmann, Elke Pogge and Koehl, Ulrike (2017). Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset. Front. Immunol., 8. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224

Koehl, Ulrike, Arsenieva, Stanislava, Holzinger, Astrid and Abken, Hinrich (2018). CAR T Cells in Trials: Recent Achievements and Challenges that Remain in the Production of Modified T Cells for Clinical Applications. Hum. Gene Ther., 29 (5). S. 559 - 569. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1557-7422

Vyas, Maulik ORCID: 0000-0003-2996-4682, Koehl, Ulrike ORCID: 0000-0002-8159-9160, Hallek, Michael and von Strandmann, Elke Pogge (2014). Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancer. Trends Mol. Med, 20 (2). S. 72 - 83. OXFORD: ELSEVIER SCI LTD. ISSN 1471-499X

Vyas, Maulik ORCID: 0000-0003-2996-4682, Schneider, Ann-Charlott, Shatnyeva, Olga, Reiners, Katrin S., Tawadros, Samir, Kloess, Stephan, Koehl, Ulrike, Hallek, Michael, Hansen, Hinrich P. and von Strandmann, Elke Pogge (2016). Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia. OncoImmunology, 5 (9). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

Weil, Sandra, Memmer, Stefanie, Lechner, Axel, Huppert, Volker, Giannattasio, Ariane, Becker, Tamara, Mueller-Runte, Andreas, Lampe, Karen, Beutner, Dirk, Quaas, Alexander, Schubert, Ralf, Herrmann, Eva, Steinle, Alexander ORCID: 0000-0001-5081-8503, Koehl, Ulrike, Walter, Lutz ORCID: 0000-0001-9408-3131, von Bergwelt-Baildon, Michael S. and Koch, Joachim (2017). Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma. Front. Immunol., 8. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224

This list was generated on Sat Oct 23 02:19:00 2021 CEST.